Literature DB >> 29095349

Clinical Implications of Pediatric Colonic Eosinophilia.

Jacob Mark1,2,3, Shahan D Fernando1,2,3, Joanne C Masterson1,3,4,5, Zhaoxing Pan1,3, Kelley E Capocelli3,5,6, Glenn T Furuta1,3,4,5, Edwin F de Zoeten1,2,4,5.   

Abstract

OBJECTIVE: Pediatric colonic eosinophilia represents a confounding finding with a wide differential. It is often difficult to determine which children may progress to inflammatory bowel disease (IBD), which have an eosinophilic colitis (EC), and which may have no underlying pathology. There is little guidance for the practitioner on the approach to these patients. To define the clinical presentations of colonic eosinophilia and identify factors which may aid in diagnosis we reviewed patients with colonic eosinophilia and the clinicopathologic factors associated with their diagnoses.
METHODS: An 8-year retrospective chart review of children whose histopathology identified colonic eosinophilia (N = 72) compared to controls with normal biopsies (N = 35).
RESULTS: Patients with colonic eosinophilia had increased eosinophils/high-power field compared to controls (P < 0.001) and had 3 clinical phenotypes. Thirty-six percent had an inflammatory phenotype with elevated erythrocyte sedimentation rate (P < .0001), chronic inflammation on colonic biopsies (P < 0.001), and were diagnosed as having IBD. Thirty-seven percent were diagnosed as having EC, associated with male sex (P < 0.005) and peripheral eosinophilia (P = 0.041). Twenty-one percent had no significant colonic pathology. Forty-three percent of patients had >1 colonoscopy and 68% of these had change from initial diagnoses.
CONCLUSIONS: There are 3 main phenotypes of children with colonic eosinophilia. Signs of chronic systemic inflammation raise suspicion for IBD. Peripheral eosinophilia and male sex are associated with EC. A significant percent of children with colonic eosinophilia do not have colonic disease. Eosinophils/high-power field is not reliable to differentiate etiologies. Repeat colonoscopies may be required to reach final diagnoses.

Entities:  

Mesh:

Year:  2018        PMID: 29095349      PMCID: PMC5916023          DOI: 10.1097/MPG.0000000000001784

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  25 in total

1.  A quantitative evaluation of mucosal eosinophils in the pediatric gastrointestinal tract.

Authors:  A Lowichik; A G Weinberg
Journal:  Mod Pathol       Date:  1996-02       Impact factor: 7.842

2.  Activated eosinophils in chronic inflammatory bowel disease.

Authors:  M Y Choy; J A Walker-Smith; C B Williams; T T MacDonald
Journal:  Lancet       Date:  1990-07-14       Impact factor: 79.321

3.  Geographic variations in eosinophil concentration in normal colonic mucosa.

Authors:  R R Pascal; T L Gramlich; K M Parker; T S Gansler
Journal:  Mod Pathol       Date:  1997-04       Impact factor: 7.842

4.  Diffuse eosinophilic gastroenteritis: an adult form of allergic gastroenteropathy. Report of a case with probable protein-losing enteropathy.

Authors:  L B Jacobson
Journal:  Am J Gastroenterol       Date:  1970-12       Impact factor: 10.864

5.  Dense eosinophilic infiltration of the mucosa preceding ulcerative colitis and mimicking eosinophilic colitis: report of two cases.

Authors:  Hülya Uzunismail; Ibrahim Hatemi; Gülen Doğusoy; Onat Akin
Journal:  Turk J Gastroenterol       Date:  2006-03       Impact factor: 1.852

Review 6.  Role of eosinophils in inflammatory bowel and gastrointestinal diseases.

Authors:  Samantha A Woodruff; Joanne C Masterson; Sophie Fillon; Zachary D Robinson; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2011-06       Impact factor: 2.839

Review 7.  Eosinophilic esophagitis: updated consensus recommendations for children and adults.

Authors:  Chris A Liacouras; Glenn T Furuta; Ikuo Hirano; Dan Atkins; Stephen E Attwood; Peter A Bonis; A Wesley Burks; Mirna Chehade; Margaret H Collins; Evan S Dellon; Ranjan Dohil; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; David A Katzka; Alfredo J Lucendo; Jonathan E Markowitz; Richard J Noel; Robert D Odze; Philip E Putnam; Joel E Richter; Yvonne Romero; Eduardo Ruchelli; Hugh A Sampson; Alain Schoepfer; Nicholas J Shaheen; Scott H Sicherer; Stuart Spechler; Jonathan M Spergel; Alex Straumann; Barry K Wershil; Marc E Rothenberg; Seema S Aceves
Journal:  J Allergy Clin Immunol       Date:  2011-04-07       Impact factor: 10.793

8.  Milk-sensitive and eosinophilic gastroenteropathy: similar clinical features with contrasting mechanisms and clinical course.

Authors:  A J Katz; F J Twarog; R S Zeiger; Z M Falchuk
Journal:  J Allergy Clin Immunol       Date:  1984-07       Impact factor: 10.793

Review 9.  Eosinophils and allergic diseases of the gastrointestinal tract.

Authors:  Stephan C Bischoff; Friedericke A Ulmer
Journal:  Best Pract Res Clin Gastroenterol       Date:  2008       Impact factor: 3.043

10.  Histologic analysis of eosinophils and mast cells of the gastrointestinal tract in healthy Canadian children.

Authors:  Elizaveta Chernetsova; Katrina Sullivan; Joseph de Nanassy; Janice Barkey; David Mack; Ahmed Nasr; Dina El Demellawy
Journal:  Hum Pathol       Date:  2016-04-01       Impact factor: 3.466

View more
  6 in total

1.  Prevalence of eosinophilic colitis and the diagnoses associated with colonic eosinophilia.

Authors:  Lauren A DiTommaso; Chen E Rosenberg; Michael D Eby; Amy Tasco; Margaret H Collins; John L Lyles; Philip E Putnam; Vincent A Mukkada; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2019-01-14       Impact factor: 10.793

2.  Increasing Rates of Diagnosis, Substantial Co-Occurrence, and Variable Treatment Patterns of Eosinophilic Gastritis, Gastroenteritis, and Colitis Based on 10-Year Data Across a Multicenter Consortium.

Authors:  Robert D Pesek; Craig C Reed; Amanda B Muir; Patricia C Fulkerson; Calies Menard-Katcher; Gary W Falk; Jonathan Kuhl; Ellen K Martin; Adam Z Magier; Faria Ahmed; Maureen Demarshall; Ankur Gupta; Jonathan Gross; Tokunbo Ashorobi; Christina L Carpenter; Jeffrey P Krischer; Nirmala Gonsalves; Jonathan M Spergel; Sandeep K Gupta; Glenn T Furuta; Marc E Rothenberg; Evan S Dellon
Journal:  Am J Gastroenterol       Date:  2019-06       Impact factor: 10.864

3.  Evaluating Eosinophilic Colitis as a Unique Disease Using Colonic Molecular Profiles: A Multi-Site Study.

Authors:  Tetsuo Shoda; Margaret H Collins; Mark Rochman; Ting Wen; Julie M Caldwell; Lydia E Mack; Garrett A Osswald; John A Besse; Yael Haberman; Seema S Aceves; Nicoleta C Arva; Kelley E Capocelli; Mirna Chehade; Carla M Davis; Evan S Dellon; Gary W Falk; Nirmala Gonsalves; Sandeep K Gupta; Ikuo Hirano; Paneez Khoury; Amy Klion; Calies Menard-Katcher; John Leung; Vincent A Mukkada; Philip E Putnam; Jonathan M Spergel; Joshua B Wechsler; Guang-Yu Yang; Glenn T Furuta; Lee A Denson; Marc E Rothenberg
Journal:  Gastroenterology       Date:  2022-01-25       Impact factor: 33.883

Review 4.  Non-IgE- or Mixed IgE/Non-IgE-Mediated Gastrointestinal Food Allergies in the First Years of Life: Old and New Tools for Diagnosis.

Authors:  Mauro Calvani; Caterina Anania; Barbara Cuomo; Enza D'Auria; Fabio Decimo; Giovanni Cosimo Indirli; Gianluigi Marseglia; Violetta Mastrorilli; Marco Ugo Andrea Sartorio; Angelica Santoro; Elisabetta Veronelli
Journal:  Nutrients       Date:  2021-01-14       Impact factor: 5.717

5.  Potent CCR3 Receptor Antagonist, SB328437, Suppresses Colonic Eosinophil Chemotaxis and Inflammation in the Winnie Murine Model of Spontaneous Chronic Colitis.

Authors:  Rhiannon T Filippone; Narges Dargahi; Rajaraman Eri; Jose A Uranga; Joel C Bornstein; Vasso Apostolopoulos; Kulmira Nurgali
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

6.  Fecal Eosinophil Cationic Protein Is a Diagnostic and Predictive Biomarker in Young Adults with Inflammatory Bowel Disease.

Authors:  Nada Abedin; Teresa Seemann; Sandra Kleinfeld; Jessica Ruehrup; Stefani Röseler; Christian Trautwein; Konrad Streetz; Gernot Sellge
Journal:  J Clin Med       Date:  2019-11-20       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.